Suppr超能文献

人血浆中纤溶酶的主要抑制剂。

The primary inhibitor of plasmin in human plasma.

作者信息

Müllertz S, Clemmensen I

出版信息

Biochem J. 1976 Dec 1;159(3):545-53. doi: 10.1042/bj1590545.

Abstract

A complex between plasmin and an inhibitor was isolated by affinity chromatography from urokinase-activated human plasma. The complex did not react with antibodies against any of the known proteinase inhibitors in plasma. A rabbit antiserum against the complex was produced. It contained antibodies agianst plasminogen+plasmin and an alpha2 protein. By crossed immunoelectrophoresis the alpha2 protein was shown to form a complex with plasmin, when generated by urokinase in plasma, and with purified plasmin. The alpha2 protein was eluted by Sephadex G-200 gel filtration with KD approx. 0.35, different from the other inhibitors of plasmin in plasma, and corresponding to an apparent relative molecular mass (Mr) of about 75000. By sodium dodecyl sulphate/polyacrylamide-gel electrophoresis, the Mr of the complex was found to be approx. 130000. After reduction of the complex two main bands of protein were observed, with Mr, about 72000 and 66000, probably representing an acyl-enzyme complex of plasmin-light chain and inhibitor-heavy chain, and a plasmin-heavy chain. A weak band with Mr 9000 was possibly an inhibitor-light chain. The inhibitor was partially purified and used to titrate purified plasmin of known active-site concentration. The inhibitor bound plasmin rapidly and strongly. Assuming an equimolar combining ratio, the concentration of active inhibitor in normal human plasma was estimated to be 1.1 mumol/1. A fraction about 0.3 of the antigenic inhibitor protein appeared to be functionally inactive. In plasma, plasmin is primarily bound to the inhibitor. Only after its saturation does lysis of fibrinogen and fibrin occur and a complex between plasmin and alpha2 macroglobulin appear.

摘要

通过亲和层析从尿激酶激活的人血浆中分离出纤溶酶与一种抑制剂的复合物。该复合物不与针对血浆中任何已知蛋白酶抑制剂的抗体发生反应。制备了针对该复合物的兔抗血清。它含有针对纤溶酶原 + 纤溶酶和一种α2蛋白的抗体。通过交叉免疫电泳表明,α2蛋白在血浆中由尿激酶产生时会与纤溶酶形成复合物,并且与纯化的纤溶酶也能形成复合物。α2蛋白通过Sephadex G - 200凝胶过滤洗脱,KD约为0.35,这与血浆中纤溶酶的其他抑制剂不同,其表观相对分子质量(Mr)约为75000。通过十二烷基硫酸钠/聚丙烯酰胺凝胶电泳,发现该复合物的Mr约为130000。复合物还原后观察到两条主要的蛋白条带,Mr分别约为72000和66000,可能分别代表纤溶酶轻链与抑制剂重链的酰基 - 酶复合物以及纤溶酶重链。一条Mr为9000的弱条带可能是抑制剂轻链。该抑制剂经过部分纯化后用于滴定已知活性位点浓度的纯化纤溶酶。该抑制剂能快速且强烈地结合纤溶酶。假设结合比例为等摩尔,估计正常人血浆中活性抑制剂的浓度为1.1 μmol/L。约0.3的抗原性抑制剂蛋白似乎没有功能活性。在血浆中,纤溶酶主要与该抑制剂结合。只有在其饱和后才会发生纤维蛋白原和纤维蛋白的溶解,并且出现纤溶酶与α2巨球蛋白的复合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6392/1164152/87395b9e8e9f/biochemj00523-0122-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验